{
    "xml": "<topic id=\"PHP8627\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/vecuronium-bromide\" basename=\"vecuronium-bromide\" title=\"VECURONIUM BROMIDE\">\n<title>VECURONIUM BROMIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_626\" namespace=\"/interactions/list-of-drug-interactions/muscle-relaxants/muscle-relaxants-non-depolarising/vecuronium\">Vecuronium</xref>\n</p>\n<data name=\"vtmid\">86085000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_514498464\" title=\"Neuromuscular blocking drugs (non-depolarising)\">Neuromuscular blocking drugs (non-depolarising)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34607\" title=\"NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS\" namespace=\"/drug-classes/non-depolarising-neuromuscular-blocking-drugs\">NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP71235\" outputclass=\"indicationsAndDose\" rev=\"1.27\" parent=\"/drugs/vecuronium-bromide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Neuromuscular blockade (intermediate duration) during surgery and intubation</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8211;100&#8239;micrograms/kg; (by intravenous injection) maintenance 20&#8211;30&#8239;micrograms/kg, adjusted according to response, max. 100&#8239;micrograms/kg in caesarian section, alternatively (by intravenous infusion) maintenance 0.8&#8211;1.4&#8239;micrograms/kg/minute, adjusted according to response.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"extremesOfBodyWeight\">\n<title>Doses at extremes of body-weight</title>\n<p>To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71158\" outputclass=\"sideEffects\" rev=\"1.10\" parent=\"/drugs/vecuronium-bromide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaphylactoid reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute myopathy (after prolonged use in intensive care)</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">skin flushing</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71272\" outputclass=\"hepaticImpairment\" parent=\"/drugs/vecuronium-bromide\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in significant impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71182\" outputclass=\"renalImpairment\" parent=\"/drugs/vecuronium-bromide\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71935\" outputclass=\"directionsForAdministration\" rev=\"1.9\" parent=\"/drugs/vecuronium-bromide\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Reconstitute each vial with 5&#8239;mL Water for Injections to give 2&#8239;mg/mL solution; <i>alternatively</i> reconstitute with up to 10&#8239;mL Glucose 5% <i>or</i> Sodium Chloride 0.9% <i>or</i> Water for Injections&#8212; unsuitable for further dilution if not reconstituted with Water for Injections.</p>\n<p>For <i>continuous intravenous infusion</i>, dilute reconstituted solution to a concentration up to 40&#8239;micrograms/L with Glucose 5% or Sodium Chloride 0.9%; reconstituted solution can also be given via drip tubing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP8627-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/vecuronium-bromide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75844\" title=\"Powder and solvent for solution for injection\" namespace=\"/drugs/vecuronium-bromide/powder-and-solvent-for-solution-for-injection\">Powder and solvent for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78426\" namespace=\"/treatment-summaries/neuromuscular-blockade\" title=\"Neuromuscular blockade\" count=\"4\" rel=\"backlink\">Neuromuscular blockade</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_626\" namespace=\"/interactions/list-of-drug-interactions/muscle-relaxants/muscle-relaxants-non-depolarising/vecuronium\" title=\"Vecuronium\" count=\"1\" rel=\"link\">Vecuronium</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34607\" namespace=\"/drug-classes/non-depolarising-neuromuscular-blocking-drugs\" title=\"NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS\" count=\"1\" rel=\"link\">NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75844\" namespace=\"/drugs/vecuronium-bromide/powder-and-solvent-for-solution-for-injection\" title=\"Powder and solvent for solution for injection\" count=\"1\" rel=\"link\">Powder and solvent for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP8627",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/vecuronium-bromide",
    "basename": "vecuronium-bromide",
    "title": "VECURONIUM BROMIDE",
    "interactants": [
        {
            "id": "bnf_int_626",
            "label": "Vecuronium"
        }
    ],
    "vtmid": "86085000",
    "drugClassification": [
        "Neuromuscular blocking drugs (non-depolarising)"
    ],
    "inheritsFromClass": [
        "NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Neuromuscular blockade (intermediate duration) during surgery and intubation",
                        "html": "Neuromuscular blockade (intermediate duration) during surgery and intubation"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "80&#8211;100 micrograms/kg; (by intravenous injection) maintenance 20&#8211;30 micrograms/kg, adjusted according to response, max. 100 micrograms/kg in caesarian section, alternatively (by intravenous infusion) maintenance 0.8&#8211;1.4 micrograms/kg/minute, adjusted according to response.",
                        "html": "<p>80&#8211;100&#8239;micrograms/kg; (by intravenous injection) maintenance 20&#8211;30&#8239;micrograms/kg, adjusted according to response, max. 100&#8239;micrograms/kg in caesarian section, alternatively (by intravenous infusion) maintenance 0.8&#8211;1.4&#8239;micrograms/kg/minute, adjusted according to response.</p>"
                    }
                ]
            }
        ],
        "extremesOfBodyWeight": [
            {
                "type": "extremesOfBodyWeight",
                "title": "Doses at extremes of body-weight",
                "textContent": "To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.",
                "html": "<p>To avoid excessive dosage in obese patients, dose should be calculated on the basis of ideal bodyweight.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Anaphylactoid reactions",
                        "html": "Anaphylactoid reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Acute myopathy (after prolonged use in intensive care)",
                        "html": "Acute myopathy (after prolonged use in intensive care)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin flushing",
                        "html": "skin flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in significant impairment.",
                "html": "<p>Use with caution in significant impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Reconstitute each vial with 5 mL Water for Injections to give 2 mg/mL solution; alternatively reconstitute with up to 10 mL Glucose 5% or Sodium Chloride 0.9% or Water for Injections&#8212; unsuitable for further dilution if not reconstituted with Water for Injections.\n\nFor continuous intravenous infusion, dilute reconstituted solution to a concentration up to 40 micrograms/L with Glucose 5% or Sodium Chloride 0.9%; reconstituted solution can also be given via drip tubing.",
                "html": "<p>Reconstitute each vial with 5&#8239;mL Water for Injections to give 2&#8239;mg/mL solution; <i>alternatively</i> reconstitute with up to 10&#8239;mL Glucose 5% <i>or</i> Sodium Chloride 0.9% <i>or</i> Water for Injections&#8212; unsuitable for further dilution if not reconstituted with Water for Injections.</p><p>For <i>continuous intravenous infusion</i>, dilute reconstituted solution to a concentration up to 40&#8239;micrograms/L with Glucose 5% or Sodium Chloride 0.9%; reconstituted solution can also be given via drip tubing.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75844",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78426",
                "label": "Neuromuscular blockade",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_626",
                "label": "Vecuronium",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34607",
                "label": "NON-DEPOLARISING NEUROMUSCULAR BLOCKING DRUGS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75844",
                "label": "Powder and solvent for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}